BioPharma-Reporter

@BioPharmaReport

BioPharma-Reporter provides the latest news, views, and issues impacting the global biomanufacturing sector.

Vrijeme pridruživanja: lipanj 2013.

Tweetovi

Blokirali ste korisnika/cu @BioPharmaReport

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @BioPharmaReport

  1. 4. velj

    WuXi Biologics advises clients against China travel during Wuhan outbreak

    Poništi
  2. 4. velj

    Takeda set to divest $400m Irish facility

    Poništi
  3. 4. velj

    FairJourney lands GHO investment to expand antibody discovery services

    Poništi
  4. 30. sij

    Bellicum offloads cell therapy plant in switch to outsourced production

    Poništi
  5. 30. sij

    Kamada raises $25M to pick up products to fill manufacturing facility

    Poništi
  6. 30. sij

    Merck builds €250m biotech R&D facility in Switzerland

    Poništi
  7. 29. sij

    New CDMO plans $1.1bn cell and gene therapy plant

    Poništi
  8. 29. sij

    J&J warns biosimilars will bite after muted impact in 2019

    Poništi
  9. 29. sij

    ARM suggests cross-border healthcare plan for ATMPs in Europe

    Poništi
  10. 28. sij

    WCG continues acquisitive streak with biostatistical consultancy buyout

    Poništi
  11. 28. sij

    Krystal Biotech continues internal buildout with second facility

    Poništi
  12. 28. sij

    Lonza poised to add 600 staff as investment peak continues into 2020

    Poništi
  13. 23. sij

    Boom in number of UK cell and gene therapy clinical trials

    Poništi
  14. 23. sij

    PACT Pharma raises $75M to expand cell therapy manufacturing

    Poništi
  15. 23. sij

    GE Healthcare anticipates demand with Swiss facility investment

    Poništi
  16. 22. sij

    Nationwide Children’s Hospital creates for-profit gene therapy CMO

    Poništi
  17. 22. sij

    Celltrion set to build largest biopharma plant in China

    Poništi
  18. 22. sij

    Health plan hails success of push to boost Remicade biosimilar use

    Poništi
  19. 21. sij

    Failure to launch? Mixed views on US biosimilar market

    Poništi
  20. 21. sij

    Sarepta tips Roche pact to spur manufacturing capacity expansion

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·